Bioanalysis Zone is part of Taylor & Francis Group.

  • Taylor & Francis
  • About us
  • Our journals
  • Our Digital Hubs

Taylor & Francis Group is a trading division of Informa that operates through various Informa legal entities including, but not limited to, Informa UK Limited, with the registered address at 5 Howick Place, London, SW1P 1WG, UK.

Taylor & Francis
logo
 
  • Home
  • Awards
  • Events
  • Features
    • An author's perspective
    • Ask the Experts
    • Conference reports
    • eBooks
    • Expert opinion
    • In the Zone
    • Journal articles
    • Journal content
    • Spotlights
    • Tech Digest

    Follow us on social media

  • Glossary
  • Topics
    • Applications
      • Advanced therapies
      • Biomarkers
      • Clinical
      • Diagnostics
      • Drug development
      • Forensics
      • Patient-centric sampling
      • Sports drug testing
      • Toxicology
      • Vaccines
    • Industry updates & regulations
      • Biopharmaceuticals
      • Collaborations & mergers
      • Data processing and interpretation
      • Regulated bioanalysis
    • Molecules
      • Antibodies | ADCs
      • Biosimilars
      • Large molecules
      • Metabolites
      • Oligonucleotides
      • Small molecules
    • Techniques
      • Automation
      • Chromatography
      • Imaging
      • LBA
      • Microsampling
      • MS (LC–MS/MS, HRMS, IMS)
      • Sample preparation

    Follow us on social media

  • Multimedia
    • Coffee chats
    • Infographics
    • Interviews
    • Panel discussions
    • Podcasts
    • Videos
    • Webinars

    Follow us on social media

  • News
  • Partners
  • Register
[WEBINAR] Molecular bioanalysis considerations along the drug development journey 11 days 20 hours 29 mins 1 secs REGISTER NOW!

Poster: The use of fragment ion and collision cross section for confident identification from LC-ION mobility-MS metabolomics data (Waters Corporation)

7 Oct 2014
General interest

A novel and confident identification of metabolomics and lipidomics UPLC-ion mobility MS datasets
bases on fragment ion and collision cross section.


Click here to view poster

Related Links

  • Waters Corporation

 

Top content

  • Waters launches the Xevo TQ Absolute XR at ASMS 2025
  • How can diagnostic laboratories accelerate the clinical adoption of allogeneic cell therapies?
  • Why NGS ELN deployments fail

Related tags

LC metabolomics MS
Previous article Next article

Related articles

31 OCT 2009 DATA PROCESSING AND INTERPRETATION

Tetrahydrogestrinone analysis and designer steroids revisited

3 SEP 2013 COLLABORATIONS AND MERGERS

Collaboration announced for development of biologics analysis

19 AUG 2016 CHROMATOGRAPHY

Solid-phase extraction: a principal option for peptide bioanalytical sample preparation

11 OCT 2012 CLINICAL

The role of metabolomics in characterizing the human exposome

25 MAR 2011 CHROMATOGRAPHY

Symposium Report: The Waters Bioanalysis World Tour: The Broadening Impact and Future of the DMPK Laboratory – Addressing Large-Molecule Therapeutics

21 AUG 2011 CHROMATOGRAPHY

Development of methods to monitor ionization modification from dosing vehicles and phospholipids in study samples

  • About
  • Advertising & Sponsorship
  • Learn
    • Awareness
    • Education zone
    • Professional development
  • Contact Us
  • Permissions
  • Products
  • Zone Leaders
  • Whitelist Emails
Contact
Contact Us
Office info

Bioanalysis Zone is powered by Taylor & Francis Group

Bioanalysis Zone, 2-4 Park Square, Milton Park, Abingdon, Oxfordshire, OX14 4RN, United Kingdom
  • Taylor & Francis Group
  • Cookie Policy
  • Privacy Policy
  • Terms & Conditions
  • © 2025 Bioanalysis Zone